METHODS OF TREATING IDIOPATHIC PULMONARY FIBROSIS WITH DEUPIRFENIDONE

Disclosed herein is a method of treating Idiopathic Pulmonary Fibrosis (IPF). The method includes administering to a subject in need thereof the deuterium-enriched pirfenidone LYT-100 at a total daily dose from about 1650 mg to about 2500 mg. Une méthode de traitement de la fibrose pulmonaire idiopa...

Full description

Saved in:
Bibliographic Details
Main Authors HATCH, SIMON JOHN, GRAHAM, CAMILLA S, MICIONI, LIZA C, KROP, JULIE S, ELENKO, ERIC, PADEN, HEATHER A, GARG, VARUN, CHEN, MICHAEL C, FORD, PAUL ANDREW, KORTH, CHRISTOPHER C
Format Patent
LanguageEnglish
French
Published 13.07.2023
Online AccessGet full text

Cover

More Information
Summary:Disclosed herein is a method of treating Idiopathic Pulmonary Fibrosis (IPF). The method includes administering to a subject in need thereof the deuterium-enriched pirfenidone LYT-100 at a total daily dose from about 1650 mg to about 2500 mg. Une méthode de traitement de la fibrose pulmonaire idiopathique (FPI) est divulguée. La méthode comprend l'administration à un patient en ayant besoin de pirfénidone LYT-100 enrichie en deutérium à une dose quotidienne totale d'environ 1 650 mg à environ 2 500 mg.
Bibliography:Application Number: CA20233239301